Developing an Integrative, Recovery-Based, Post-Acute COVID-19 Syndrome (PACS) Psychotherapeutic Intervention
制定综合性、基于恢复的急性后 COVID-19 综合症 (PACS) 心理治疗干预措施
基本信息
- 批准号:10683267
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-10-01 至 2024-09-30
- 项目状态:已结题
- 来源:
- 关键词:Activities of Daily LivingAcuteAddressAmericanAnxietyAnxiety DisordersCOVID-19COVID-19 patientCardiovascular systemCaringChaplainChronicClimactericClinicalConsultationsContractsCoping SkillsCoupledDataDevelopmentDiseaseDistressEducationEducational process of instructingEmploymentEpidemiologyFatigueFeedbackFosteringFutureGoalsHeadacheHealthHigh PrevalenceImpairmentIndividualInfectionInterventionInterviewKnowledgeLeadershipLifeLife StyleLonelinessLong COVIDLongitudinal StudiesMeasuresMedicalMemory impairmentMental DepressionMental HealthMental disordersModelingNeeds AssessmentNeurologicNeurologic SymptomsNutritionistPainPain DisorderParticipantPatientsPersonsPhasePopulationPost-Traumatic Stress DisordersPrevalenceProcessProtocols documentationProviderPsychological adjustmentPsychotherapyQuality of lifeRecoveryRegistriesRehabilitation therapySamplingServicesSleep DisordersSleeplessnessSpecialistSymptomsTechniquesTestingTimeUnited StatesUnited States Department of Veterans AffairsUnited States National Institutes of HealthVeteransacceptability and feasibilityarmarthropathiescohortcommon symptomcopingcoronavirus diseasedesignempowermentexperiencefitnessflexibilityfollow-upfunctional disabilityfunctional improvementfunctional restorationfunctional statusgroup interventionhealth assessmentimprovedimprovement on sleepinnovationinterdisciplinary approachintervention refinementmedical schoolsnoveloptimismphysical conditioningpost SARS-CoV-2 infectionprogramspromote resiliencepsychosocialpulmonary symptomrelapse preventionresiliencesatisfactionskillsskills trainingsymptomatologytelehealththerapy developmentwhole health
项目摘要
Project Abstract
At present, 34.6 million people in the United States, and 273,232 Veterans tested or treated in Veteran Affairs
facilities contracted COVID-19. While the exact prevalence of Post-Acute COVID-19 Syndrome (PACS) among
Veterans is unknown, estimates of psychiatric/neurological PACS using a large global sample of COVID-19
patients (N=236,379) suggest a prevalence of approximately 11,390,400 Americans, and 90,311 Veterans in
VA care, with rates likely to increase over time. Moreover, large scale studies suggest up to 35% of individuals
experience functional impairment 8 months after COVID-19, and high prevalence of post-infection mental illness
including anxiety disorders, depression, and post-traumatic stress disorder. Using longitudinal data from our
academic affiliate, Icahn School of Medicine at Mount Sinai’s COVID registry (n≈1200), and local James J. Peters
VA’s Clinical PACS program, coupled with our expertise in recovery-based psychotherapy, we are uniquely
poised to develop an innovative treatment for Veterans struggling with PACS.
Our intervention aims to improve psychological adjustment to PACS symptoms, promote resiliency, and facilitate
coping, all of which can impact functional status and quality of life. The PACS-Coping and Recovery (PACS-CR)
intervention we aim to develop focuses on psychological adjustment and coping, and augments medical,
rehabilitative and neurological treatment for this population. Our approach is based on the CHIME model of
personal recovery which includes five overarching processes: 1) Connectedness; 2) Hope and optimism about
the future; 3) Identity; 4) Meaning in life; and 5) Empowerment. We will target the CHIME processes using
established psychotherapeutic techniques such as skills training, acceptance-based and identity-based
principles.
Based on adaptations from existing recovery-based and COVID-19 distress group interventions that our team
has developed and piloted, we are proposing a treatment framework that consists of a core of twelve 90-minutes
sessions (1x/week x 12 weeks) with additional weekly sessions on specialized topics that are optional. We are
proposing a treatment development NIH Stage 1A study to develop a Post-Acute COVID-19 Syndrome
psychotherapeutic intervention, “PACS Coping and Recovery” (PACS-CR) through an iterative development
process while collecting pilot data to assess its acceptability and feasibility.
Our treatment development SPiRE will focus on 1) determining the treatment needs of Veterans with PACS, 2)
developing the treatment using pilot qualitative data and aided by stakeholder feedback, 3) refining the
intervention by three iterative pilots of our groups, testing both in person and telehealth versions. Pre and post
measures will be utilized to track functional improvement and the degree to which this recovery-focused
intervention has enabled the veterans to engage in meaningful life changes.
项目摘要
目前,美国有3,460万人,在资深事务中进行了测试或治疗的273,232名退伍军人
设施签约了Covid-19。虽然急性后共证综合征(PAC)的确切患病率
退伍军人是未知的,使用大量全球covid-19对精神病/神经系统PAC的估计
患者(n = 236,379)表明,大约11,390,400名美国人的患病率和90,311名退伍军人
VA护理,费率可能会随着时间而增加。此外,大规模研究表明多达35%的个体
经历功能障碍,在COVID-19之后8个月,感染后精神疾病的高患病率很高
包括焦虑症,抑郁症和创伤后应激障碍。使用我们的纵向数据
西奈山登记处(N≈1200)和当地詹姆斯·J·彼得斯(James J. Peters)的学术会员,伊坎医学院
VA的临床PACS计划,再加上我们在基于恢复心理治疗方面的专业知识,我们是独特的
被毒性为退伍军人与PACS斗争的创新待遇。
我们的干预旨在改善对PACS符号的心理调整,促进弹性并促进
应对,所有这些都会影响功能状况和生活质量。 PACS培训和恢复(PACS-CR)
干预措施我们旨在发展侧重于心理调整和应对,并增强医学,
该人群的康复和神经治疗。我们的方法基于
个人恢复包括五个总体过程:1)连接; 2)对
未来; 3)身份; 4)生活中的意义; 5)授权。我们将使用
建立的心理治疗技术,例如技能培训,基于认可和基于身份的技术
原则。
基于我们团队现有的基于恢复和共同的遇险小组干预措施的改编
已经开发和驾驶,我们提出了一个由十二个90分钟的核心组成的治疗框架
会议(1x/周x 12周),每周一次,额外关于可选的专业主题。我们是
提出一项治疗开发NIH 1A阶段研究,以发展急性后Covid-19综合征
心理治疗干预,“ PACS应对和恢复”(PACS-CR)通过迭代发展
在收集飞行员数据以评估其可接受性和可行性的同时进行处理。
我们的治疗开发尖峰将重点放在1)确定PAC的退伍军人的治疗需求,2)
使用飞行员定性数据开发治疗,并在利益相关者的反馈下帮助,3)完善
我们小组的三个迭代小球的干预,亲自测试和远程医疗版本。前后
措施将用于跟踪功能改进以及以这种恢复为中心的程度
干预使退伍军人能够从事有意义的生活变化。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Marianne Goodman其他文献
Marianne Goodman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Marianne Goodman', 18)}}的其他基金
Center for Harmonizing and Improving Interventions to Prevent Suicide (CHIIPS)
协调和改进预防自杀干预措施中心 (CHIIPS)
- 批准号:
10662785 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Developing an Integrative, Recovery-Based, Post-Acute COVID-19 Syndrome (PACS) Psychotherapeutic Intervention
制定综合性、基于恢复的急性后 COVID-19 综合症 (PACS) 心理治疗干预措施
- 批准号:
10586328 - 财政年份:2022
- 资助金额:
-- - 项目类别:
CTBI: Traumatic brain injury-induced inflammation effects on cognitive evaluations and response inhibition: Mechanisms of increased risk forsuicidality
CTBI:创伤性脑损伤诱发的炎症对认知评估和反应抑制的影响:自杀风险增加的机制
- 批准号:
10425246 - 财政年份:2020
- 资助金额:
-- - 项目类别:
CTBI: Traumatic brain injury-induced inflammation effects on cognitive evaluations and response inhibition: Mechanisms of increased risk forsuicidality
CTBI:创伤性脑损伤诱发的炎症对认知评估和反应抑制的影响:自杀风险增加的机制
- 批准号:
10662374 - 财政年份:2020
- 资助金额:
-- - 项目类别:
CTBI: Traumatic brain injury-induced inflammation effects on cognitive evaluations and response inhibition: Mechanisms of increased risk for suicidality
CTBI:创伤性脑损伤诱发的炎症对认知评估和反应抑制的影响:自杀风险增加的机制
- 批准号:
10558287 - 财政年份:2020
- 资助金额:
-- - 项目类别:
CTBI: Traumatic brain injury-induced inflammation effects on cognitive evaluations and response inhibition: Mechanisms of increased risk forsuicidality
CTBI:创伤性脑损伤诱发的炎症对认知评估和反应抑制的影响:自杀风险增加的机制
- 批准号:
9889256 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Group (“Project Life Force”) vs. Individual Suicide Safety Planning RCT
团体(“生命力计划”)与个人自杀安全计划随机对照试验
- 批准号:
10038807 - 财政年份:2018
- 资助金额:
-- - 项目类别:
Group (“Project Life Force”) vs. Individual Suicide Safety Planning RCT
团体(“生命力计划”)与个人自杀安全计划随机对照试验
- 批准号:
10594391 - 财政年份:2018
- 资助金额:
-- - 项目类别:
Group (“Project Life Force”) vs. Individual Suicide Safety Planning RCT
团体(“生命力计划”)与个人自杀安全计划随机对照试验
- 批准号:
9561655 - 财政年份:2018
- 资助金额:
-- - 项目类别:
Group (“Project Life Force”) vs. Individual Suicide Safety Planning RCT
团体(“生命力计划”)与个人自杀安全计划随机对照试验
- 批准号:
10295174 - 财政年份:2018
- 资助金额:
-- - 项目类别:
相似国自然基金
阿魏酸基天然抗氧化抗炎纳米药物用于急性肾损伤诊疗一体化研究
- 批准号:82302281
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于hemin-MOFs的急性心肌梗塞标志物负背景光电化学-比色双模分析
- 批准号:22304039
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
RNA甲基转移酶NSUN2介导SCD1 mRNA m5C修饰调控急性髓系白血病细胞铁死亡的机制研究
- 批准号:82300173
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于IRF5/MYD88信号通路调控巨噬细胞M1极化探讨针刀刺营治疗急性扁桃体炎的机制研究
- 批准号:82360957
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:地区科学基金项目
相似海外基金
Pterygopalatine Fossa (PPF) Block as an Opioid Sparing Treatment for AcuteHeadache in Aneurysmal Subarachnold Hemorrhage
翼腭窝 (PPF) 阻滞作为阿片类药物节省治疗动脉瘤性蛛网膜下腔出血的急性头痛
- 批准号:
10584712 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Cognitive aging in long-term breast cancer survivors
长期乳腺癌幸存者的认知衰老
- 批准号:
10566264 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Next Generation Opto-GPCRs for Neuromodulatory Control
用于神经调节控制的下一代 Opto-GPCR
- 批准号:
10515612 - 财政年份:2023
- 资助金额:
-- - 项目类别:
The Protective and Pathologic Features of the EVD Survivor Immune System
埃博拉病毒病幸存者免疫系统的保护和病理特征
- 批准号:
10639583 - 财政年份:2023
- 资助金额:
-- - 项目类别: